Let us assume that at some point during evolution, an amino acid containing a rare chem- ical element was used and this amino acid was incorporated at a specific codon. In this, case, termination of translation at such codon will be beneficial when bacteria are placed in a habitat lacking ...
J. Biol. Chem. 284, 35092–35100, doi: 10.1074/jbc.M109.022525 (2009). 61. Matamoros, T. et al. Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by α-phosphate- modified thymidine analogues. J. Mol. Biol. 349, 451–463, doi: 10.1016/j.jmb....
Clin Chem 44(3): 455–462. Wiman KG (2006) Strategies for therapeutic targeting of the p53 pathway in cancer. Cell Death Differ 13(6): 921–926. Yamada T, Fialho AM, Punj V, Bratescu L, Gupta TK, Chakrabarty AM (2005) Internalization of bacterial redox protein azurin in mammalian ...
J. Biol. Chem. 1992, 267, 1569–1575. [Google Scholar] Steinhagen, H.; Gerisch, M.; Mittendorf, J.; Schlemmer, K.H.; Albrecht, B. Substituted uracil derivatives as potent inhibitors of poly (ADP-ribose) polymerase-1 (PARP-1). Bioorg. Med. Chem. Lett. 2002, 12, 3187–3190. [...
in vivCooamppplairceadtiotonst.he SPIO nanoparticles with a very high r2 value and an appreciable r2/r1 ratio (TablCeo3m) [p1a5r,5e2d,5t3o],tthheeSDPYIOO@nCannoapnaorptiacrletisclwesitahrealevsesrypohwigehrfur2l vbaelcuaeusaenodf athneiarpspmreaclliearblre2 vr2a/lru1 er,abtiuot...
J. Med. Chem. 2008, 51, 347–372. [CrossRef] [PubMed] 40. Rosini, M.; Simoni, E.; Minarini, A.; Melchiorre, C. Multi-target design strategies in the context of Alzheimer's disease: Acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces. Neurochem. Res. ...
Second, the best ChemPLP score pose only was conserved for each compound. A score per atom was also calculated by dividing this score by the number of heavy atoms of the compound, to keep the embedment of the molecule as a guideline. The more buried in the cavity a compound is, the ...
Food Chem. 2015, 183, 111–114. [CrossRef] 22. Cha, S.H.; Kim, S.H.; Bischoff, K.; Kim, H.J.; Son, S.W.; Kang, H.G. Production of a highly group-specific monoclonal antibody against zearalenone and its application in an enzyme-linked immunosorbent assay. J. Vet. Sci. ...
It has a similar chem- ical structure to seliciclib (roscovitine), which is the first selective oral cyclin-dependent kinase (CDK) inhibitor to enter the clinical trial (NCT03774446). Preclinical studies showed antitumor activity of seliciclib in a broad range of human tumor xenografts [8]. ...
PyMol 1.3 version was used to visualise and evaluate, as well as analyse, the generated 3-D model [21]. Vaccines 2018, 6, 1 9 of 12 Based on the fact that there is no existing vaccine against cancer, this present study was designed to give an insight towards therapeutic vaccine ...